Senate Bill 1215 Printer's Number 1502
PENNSYLVANIA, March 13 - with subclause (A). If any individual ingredient does not have a
valid and recognized NDC number, the compound drug shall not be
reimbursed. The following shall apply:
(I) A retail pharmacy, mail order pharmacy or physician
shall be reimbursed a single compounding fee of twenty dollars
($20) per prescription filled and dispensed.
(II) In no instance shall reimbursement for a compound drug
exceed four hundred dollars ($400) per thirty-day supply or a
prorated amount if the supply is greater or less than thirty
days.
(III) A compound drug that is essentially a duplicate of a
commercially available drug product is not reimbursable. The
status of a compound drug as essentially a duplicate of a
commercially available drug product shall be determined pursuant
to 21 U.S.C. § 353b (relating to outsourcing facilities).
(G.2) The reimbursement for any noncompound topical drug
shall be the lesser of one hundred and ten per centum of the
AWP, the Federal Upper Limit as established by the Centers for
Medicare and Medicaid Services pursuant to 42 U.S.C. § 1396r-
8(e)(4) (relating to payment for covered outpatient drugs) and
42 CFR 447.514 (relating to upper limits for multiple source
drugs) or two hundred forty dollars ($240) for a thirty-day
supply, prorated if the supply is greater or less than thirty
days, plus a single dispensing fee of ten dollars ($10) per
prescription.
* * *
(J) As used in this subclause:
"Compound drug" shall mean a non-Food and Drug Administration
approved pharmaceutical preparation that is prescribed by a
physician and prepared by a licensed pharmacist or physician by
20260SB1215PN1502 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.